Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases
- PMID: 36009152
- PMCID: PMC9405576
- DOI: 10.3390/brainsci12081090
Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases
Abstract
Exendin-4 (Ex-4), better known in its synthetic form and used clinically as exenatide, currently applied in the treatment of diabetes, induces a beneficial impact on nerve cells, and shows promising effects in obstructive lung diseases. At an advanced age, the development of the neurodegenerative process of brain tissue is masked by numerous concomitant diseases. The initial latent phase of neurodegenerative disease results in occurrence of manifestations at an advanced stage. To protect the brain and to simultaneously ensure proper treatment of common coexisting conditions in late life, such as diabetes, chronic obstructive pulmonary disease, or asthma, a pleiotropic medication should be chosen. Molecular mechanisms of Ex-4 exert neuroprotective effects or lead to secondary neurogenesis. Additionally, Ex-4 plays an important role in anti-inflammatory actions which are necessary both in the case of asthma and Parkinson's disease. Specific receptors in the lungs also reduce the secretion of surfactants, which decreases the risk of exacerbation in chronic obstructive lung disease. In a great number of patients suffering from diabetes, asthma, or chronic lung disease, there is a great potential for both treatment of the main condition and protection against brain neurodegeneration.
Keywords: Alzheimer’s; COPD; Ex-4; anti-inflammation; asthma; elderly; hypoxia; neurodegeneration.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.PLoS One. 2012;7(2):e32008. doi: 10.1371/journal.pone.0032008. Epub 2012 Feb 23. PLoS One. 2012. PMID: 22384126 Free PMC article.
-
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4.Age (Dordr). 2012 Oct;34(5):1211-24. doi: 10.1007/s11357-011-9303-8. Epub 2011 Sep 8. Age (Dordr). 2012. PMID: 21901364 Free PMC article.
-
Impact of the Local Inflammatory Environment on Mucosal Vitamin D Metabolism and Signaling in Chronic Inflammatory Lung Diseases.Front Immunol. 2020 Jul 10;11:1433. doi: 10.3389/fimmu.2020.01433. eCollection 2020. Front Immunol. 2020. PMID: 32754156 Free PMC article. Review.
-
Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.CNS Drugs. 2012 Oct 1;26(10):871-82. doi: 10.2165/11635890-000000000-00000. CNS Drugs. 2012. PMID: 22938097 Review.
-
Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial.JMIR Res Protoc. 2017 Oct 23;6(10):e204. doi: 10.2196/resprot.7522. JMIR Res Protoc. 2017. PMID: 29061556 Free PMC article.
Cited by
-
GLP-1 in the Hypothalamic Paraventricular Nucleus Promotes Sympathetic Activation and Hypertension.J Neurosci. 2024 May 22;44(21):e2032232024. doi: 10.1523/JNEUROSCI.2032-23.2024. J Neurosci. 2024. PMID: 38565292 Free PMC article.
-
Potential association between obstructive lung diseases and cognitive decline.Front Immunol. 2024 Jul 22;15:1363373. doi: 10.3389/fimmu.2024.1363373. eCollection 2024. Front Immunol. 2024. PMID: 39104536 Free PMC article.
-
Asthma and COPD Beyond the Airways: Exploring Neurocognitive Links Through NF-κB Subunits c-Rel and p65.Int J Mol Sci. 2025 May 29;26(11):5217. doi: 10.3390/ijms26115217. Int J Mol Sci. 2025. PMID: 40508027 Free PMC article.
-
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2023 Feb 15;18:129-137. doi: 10.2147/COPD.S393323. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 36815056 Free PMC article. Review.
-
Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities.Drugs Aging. 2023 Jul;40(7):605-619. doi: 10.1007/s40266-023-01038-0. Epub 2023 Jun 14. Drugs Aging. 2023. PMID: 37316689 Free PMC article. Review.
References
-
- Athauda D., Maclagan K., Skene S.S., Bajwa-Joseph M., Letchford D., Chowdhury K., Hibbert S., Budnik N., Zampedri L., Dickson J., et al. Exenatide once weekly versus placebo in Parkinson’s disease: A randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1664–1675. doi: 10.1016/S0140-6736(17)31585-4. - DOI - PMC - PubMed
-
- Li Y., Chigurupati S., Holloway H.W., Mughal M., Tweedie D., Bruestle D.A., Mattson M.P., Wang Y., Harvey B.K., Ray B., et al. Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:e32008. doi: 10.1371/journal.pone.0032008. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
